Envista Holdings Corporation

NVST · NYSE · ·

Comparar

24,66 US$-2,5 %cierre 12 nov

Cifras hasta el 2 de octubre de 2026, del 10-Q presentado el 4 de noviembre de 2026

1W: -2,0 %
1M: +8,1 %

Acciones de Envista Holdings Corporation (NVST) — ¿es un buen negocio? — InspectStocks

Envista Holdings Corporation

NVST · NYSE · ·

Comparar

24,66 US$-2,5 %cierre 12 nov

Cifras hasta el 2 de octubre de 2026, del 10-Q presentado el 4 de noviembre de 2026

1W: -2,0 %
1M: +8,1 %

Just reported

Q3 2026 results

From Envista's results release of 4 de noviembre de 2026; its quarterly report has since been filed.

Revenue
Actual
691,5M US$
+3,2 % y/y
-5,3 % q/q
Guided
—
No guide given
EPS, GAAP
Actual
3,11 US$
Guided
—
No guide given
EPS, adjusted: 0,40 US$
Operating income, GAAP
Actual
515,2M US$
Guided
—
No guide given

Company outlook

Full year 2026

EPS, adjusted1,54 US$ – 1,58 US$Raised +2,3 %

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Medical Instruments and Supplies

Graded A or B and worth $2B or more: A first, then the largest.

All 49 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Cómo gana dinero

Specialty Products & Technologies65 %
Equipment & Consumables35 %

Los porcentajes de ingresos son estimaciones para six months ended July 3, 2026, no cifras de un informe oficial.

Compite con

Qué vende6

Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.

Mostrar 3 más

Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.

Quién se lo compra6

General dentists buy imaging equipment, restorative materials, instruments, and other supplies for their practices, directly or through distributors.
Oral surgeons, periodontists, and other dental specialists buy implant systems, surgical products, and related planning tools.
Orthodontists buy brackets, wires, clear aligners, and treatment-planning tools.

Mostrar 3 más

Dental service organizations (DSOs), which operate groups of dental practices, buy products across several categories for use across their practices.
Dental laboratories buy products used to make dental restorations and other lab work.
Third-party distributors buy Envista products for resale to dental practices; they distributed 42% of the company’s products (2025, high). Henry Schein accounted for 12% of Envista sales (2025, high).

En qué se apoya y qué podría romperlo

De qué depende el negocio

1Some specially specified or qualified materials, components, or services come from a single supplier or a limited number of suppliers, so interruptions could delay production.
2Envista relies on distributors and other channel partners to reach customers; channel partners accounted for 89% of Equipment & Consumables segment sales (2025, high).
3Its products are subject to medical-device and other healthcare rules in the United States and other countries, including requirements for product clearances, manufacturing quality, and post-sale reporting.
4Demand for some dental procedures depends on patients’ ability or willingness to pay, since many dental costs are paid out of pocket.

Qué podría salir mal

1Trade duties can raise the cost of imported products and components. Envista reported tariff costs and uncertainty about the timing and recovery of some tariff refunds in its latest quarterly report.
2China’s volume-based procurement policies have cut prices for dental and medical consumables, which can reduce revenue from products sold into that market.
3Envista depends on distributors for a substantial portion of sales, and Henry Schein alone accounted for 12% of sales (2025, high); a change in that relationship or in its purchasing could affect sales.

Estados financieros completos →

Sobre Envista Holdings Corporation

Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.

Sede: Brea, California
Fundada en: 2018
Empleados: approximately 12,000 (December 31, 2025, high)
Cotiza en: NYSE
Cierre del ejercicio: December 31

Construido a partir de los propios informes de Envista Holdings Corporation ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.

Just reported